# Clustering Approach 7 : MRNASEQ_CNMF
Index	Clinical feature name	Test type	P value	Comment
1	Time to Death	logrank test	8.14441716234793e-06	Range of duration = 0.03 to 223.96, nDeath = 79, nCensor = 173
2	AGE	ANOVA	0.0037797240691894	Range of values = 38 to 86, Mean = 65.5804, StdDev = 9.64775, nMissing = 31
3	GENDER	Chi-square test	0.0537088718846671	nTypes = 2 (FEMALE/MALE), nPatients = 155/131
4	KARNOFSKY.PERFORMANCE.SCORE	ANOVA	0.410976380364295	Range of values = 0 to 100, Mean = 74.2308, StdDev = 33.7251, nMissing = 260
5	HISTOLOGICAL.TYPE	Chi-square test	0.270892525673385	nTypes = 11 (LUNG ACINAR ADENOCARCINOMA/LUNG ADENOCARCINOMA MIXED SUBTYPE/LUNG ADENOCARCINOMA- NOT OTHERWISE SPECIFIED (NOS)/LUNG BRONCHIOLOALVEOLAR CARCINOMA MUCINOUS/LUNG BRONCHIOLOALVEOLAR CARCINOMA NONMUCINOUS/LUNG CLEAR CELL ADENOCARCINOMA/LUNG MICROPAPILLARY ADENOCARCINOMA/LUNG MUCINOUS ADENOCARCINOMA/LUNG PAPILLARY ADENOCARCINOMA/LUNG SOLID PATTERN PREDOMINANT ADENOCARCINOMA/MUCINOUS (COLLOID) ADENOCARCINOMA), nPatients = 6/64/181/3/10/2/3/2/10/1/4
6	PATHOLOGY.T	Chi-square test	0.182200383388763	nTypes = 4 (T1/T2/T3/T4), nPatients = 79/167/23/16, nMissing = 1
7	PATHOLOGY.N	Chi-square test	0.00208014174048338	nTypes = 3 (N0/N1/N2+N3), nPatients = 171/58/51, nMissing = 6
8	PATHOLOGICSPREAD(M)	Chi-square test	0.792459575310808	nTypes = 3 (M0/M1/MX), nPatients = 199/16/64, nMissing = 7
9	TUMOR.STAGE	Chi-square test	0.0719854487143877	nTypes = 4 (I/II/III/IV), nPatients = 147/61/57/16, nMissing = 5
10	RADIATIONS.RADIATION.REGIMENINDICATION	Chi-square test	0.652482768847309	nTypes = 2 (NO/YES), nPatients = 17/269
11	NEOADJUVANT.THERAPY	Chi-square test	0.0261598124477823	nTypes = 2 (NO/YES), nPatients = 44/242